|
Company Profile The Company is a developer of software technology, conceiving, developing and commercializing innovative applications derived from its core technology. The Company has two main development arms, HTTP Software Plc ("Software") and HTTP Insights Ltd. ("Insights" and now "Medicsight"). The Company's principal core technology is a Stochastic Perception Engine, an advanced data analysis system that processes unstructured data into meaningful outputs, enabling it to be interpreted or further manipulated by users of a specific application. The Company's proprietary Stochastic Perception Engine is comprised of four principal data-processing capabilities: cluster analysis, statistical modeling, classification and prediction, which when uniquely combined offer unsurpassed processing speed, accuracy and comprehensiveness of results compared to existing data analysis systems. The Company announced on September 20, 2001 that it will focus on its medical technology business as it prepares to launch its proprietary Medicsight system, the "...world's first fully automated digital cancer detection system, optimizing the increasing growth opportunities of early cancer detection in the medical technology industry. Its revolutionary Medicsight early cancer detection system, which analyzes the digital data produced by medical scanners, such as CAT and MRI scans, at levels of speed and accuracy never before achieved. Upon its launch, Medicsight will be first-to-market with its next-generation computer-aided diagnosis technology. Because lung cancer has the highest mortality rate of all cancers and is usually already at the terminal stage when first detected, the company will initially concentrate on lung cancer detection and broaden its application to other cancer screening following its launch". Reflecting HTTP's core focus on the system, it has renamed its medical technology division to Medicsight Limited from HTTP Medical Limited. |